Effect of Intermittent Pressure in Patients With PAD

NCT03854097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2021-08-06

No results posted yet for this study

Summary

The study will evaluate the effect of intermittent negative pressure (INP) on peripheral arterial disease (PAD) patient vascular function and blood flow. Patients will be given either -40mmHg INP or -10mmHg INP which will act as a placebo. Healthy volunteers will be given -40mmHg INP to evaluate changes in vascular function and blood flow with INP in healthy physiology.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Active Intermittent Negative Pressure (INP)

Application of -40mmHg negative pressure on the lower limb

DEVICE

Placebo Intermittent Negative Pressure (INP)

Application of -10mmHg negative pressure on the lower limb

Sponsors & Collaborators

  • University of Dundee

    lead OTHER

Principal Investigators

  • Jody McIntosh · PhD student

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-16
Primary Completion
2021-06-05
Completion
2021-06-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03854097 on ClinicalTrials.gov